Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Niaspan plus simvastatin on coronary microcirculation and myocardial perfusion reserve in diabetic patients
2006-000569-13Phase 3Active
- Sponsor
- Cardioangiologisches Centrum Bethanien
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of niacin in type 2 diabetes mellitus (T2DM), coronary arteriosclerosis and dyslipidemia (2 arms), sponsored by Cardioangiologisches Centrum Bethanien. Primary endpoint: Myocardial perfusion reserve after 12 months. Started Aug 2006; status: active.
02
Drugs
niacin
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosisdyslipidemia
Beyond the preview
Go deeper on 2006-000569-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000569-13.